Siti Hafsyah Idris | Universiti Teknologi Mara (original) (raw)
Papers by Siti Hafsyah Idris
2012 14th International Conference on Transparent Optical Networks (ICTON), 2012
ABSTRACT The last mile solutions for high-speed high-capacity optical networks capable of securel... more ABSTRACT The last mile solutions for high-speed high-capacity optical networks capable of securely supporting large number of simultaneous users by minimal hardware requirements are needed but it seems that any such solutions are still far away. Access networks based only on a wavelength-division multiplexing (WDM), optical timedivision multiplexing (OTDM) or optical code-division multiplexing (OCDM) schemes can't do it as the standalone systems. Here we present a proof-of-concept field demonstration of the implementation of an incoherent OCDMA over OTDMA system (iOCDM-OTDM) using a 17km long bidirectional fiber link installed between the Strathclyde and Glasgow Universities. The performed system performance analyses include system scalability calculations and a system reach under the influence of transmission link physical impairments.
Advancements in Genetic Engineering, 2013
Despite the (serious) global concerns about the safety and genetic stability of genetically modif... more Despite the (serious) global concerns about the safety and genetic stability of genetically modified organisms, the Malaysian National Biosafety Board (NBB) has recently approved the field testing for genetically modified (GM) male mosquitoes. With this development, bioethical issues, which in some respect could adversely impinge on the social, economic and environmental aspects of the society, have surfaced, and these concerns must be addressed by the authorities concerned. In reviewing this application, the National Biosafety Board has followed the requirements of the Biosafety Act 2007, which was created to strike a balance between promoting biotechnology and at the same time protecting against its potential environmental and human health risks in Malaysia. However, the 2007 Act fails to adequately take into account any bioethical issues in spite of the inclusion of a provision on socio-economic consideration. As part of an ongoing doctoral research project, and by way of an instrumental critique of the 2007 Act, the present paper attempts to address the role and function of the Malaysia biosafety legal framework in governing bioethical concerns relating to Genetically Modified Organisms (GMOs) within the current biotechnology background in Malaysia. Additionally, the paper suggests that the ambiguity of the provisions contained within the 2007 Act in governing such concerns, representing wider societal interests and welfare, in some ways might defeat the balancing role that this act was originally intended to fulfil.
The integration of public engagement in the biosafety regulatory processes through analytically s... more The integration of public engagement in the biosafety regulatory processes through analytically sound research is an important step toward the good governance of modern biotechnology. Yet questions remain about the extent to which decision-makers have actually transformed their policy practice to embrace democratic governance of biosafety decision-making. Despite the inclusion of a provision on public participation in the Biosafety Act 2007 (“the 2007 Act”) that has been created to govern the biotechnology industry in Malaysia, the said Act lacks the force in addressing this issue. Drawn from an ongoing research, the paper attempts to examine not only the justification for engaging the public and its extent in any biosafety decision-making but also the challenges that might be encountered in achieving this participatory practices. Towards this end, this paper will highlight the concept of public participation in such decision-making process. Also the paper will examine the role of the 2007 Act and its adequacy in Malaysia in promoting public participation in biosafety decision-making. The paper concludes that public participation at all stages in any biosafety decision-making is critical for the effectiveness of the biosafety regulatory frameworks and in promoting informed policy and decisions.
2012 14th International Conference on Transparent Optical Networks (ICTON), 2012
ABSTRACT The last mile solutions for high-speed high-capacity optical networks capable of securel... more ABSTRACT The last mile solutions for high-speed high-capacity optical networks capable of securely supporting large number of simultaneous users by minimal hardware requirements are needed but it seems that any such solutions are still far away. Access networks based only on a wavelength-division multiplexing (WDM), optical timedivision multiplexing (OTDM) or optical code-division multiplexing (OCDM) schemes can't do it as the standalone systems. Here we present a proof-of-concept field demonstration of the implementation of an incoherent OCDMA over OTDMA system (iOCDM-OTDM) using a 17km long bidirectional fiber link installed between the Strathclyde and Glasgow Universities. The performed system performance analyses include system scalability calculations and a system reach under the influence of transmission link physical impairments.
Advancements in Genetic Engineering, 2013
Despite the (serious) global concerns about the safety and genetic stability of genetically modif... more Despite the (serious) global concerns about the safety and genetic stability of genetically modified organisms, the Malaysian National Biosafety Board (NBB) has recently approved the field testing for genetically modified (GM) male mosquitoes. With this development, bioethical issues, which in some respect could adversely impinge on the social, economic and environmental aspects of the society, have surfaced, and these concerns must be addressed by the authorities concerned. In reviewing this application, the National Biosafety Board has followed the requirements of the Biosafety Act 2007, which was created to strike a balance between promoting biotechnology and at the same time protecting against its potential environmental and human health risks in Malaysia. However, the 2007 Act fails to adequately take into account any bioethical issues in spite of the inclusion of a provision on socio-economic consideration. As part of an ongoing doctoral research project, and by way of an instrumental critique of the 2007 Act, the present paper attempts to address the role and function of the Malaysia biosafety legal framework in governing bioethical concerns relating to Genetically Modified Organisms (GMOs) within the current biotechnology background in Malaysia. Additionally, the paper suggests that the ambiguity of the provisions contained within the 2007 Act in governing such concerns, representing wider societal interests and welfare, in some ways might defeat the balancing role that this act was originally intended to fulfil.
The integration of public engagement in the biosafety regulatory processes through analytically s... more The integration of public engagement in the biosafety regulatory processes through analytically sound research is an important step toward the good governance of modern biotechnology. Yet questions remain about the extent to which decision-makers have actually transformed their policy practice to embrace democratic governance of biosafety decision-making. Despite the inclusion of a provision on public participation in the Biosafety Act 2007 (“the 2007 Act”) that has been created to govern the biotechnology industry in Malaysia, the said Act lacks the force in addressing this issue. Drawn from an ongoing research, the paper attempts to examine not only the justification for engaging the public and its extent in any biosafety decision-making but also the challenges that might be encountered in achieving this participatory practices. Towards this end, this paper will highlight the concept of public participation in such decision-making process. Also the paper will examine the role of the 2007 Act and its adequacy in Malaysia in promoting public participation in biosafety decision-making. The paper concludes that public participation at all stages in any biosafety decision-making is critical for the effectiveness of the biosafety regulatory frameworks and in promoting informed policy and decisions.